Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer-Reference-Cited by-同舟云学术

Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer

Published:2021-11 Issue:6 Volume:20 Page:1099-1106
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Gorovets Daniel^ORCID,Hopkins Margaret,Kollmeier Marisa,Moore Assaf,Goel Arun^ORCID,Shasha Daniel,Brennan Victoria^ORCID,McBride Sean,Cohen Gilad,Damato Antonio L.,Zelefsky Michael J.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference36 articles.

1. Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: the NRG oncology RTOG 0126 randomized clinical trial;Michalski;JAMA Oncol,2018

2. Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival;Heemsbergen;Radiother Oncol J Eur Soc Ther Radiol Oncol,2014

3. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?;Kuban;Int J Radiat Oncol Biol Phys,2011

4. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol,2014

5. 70 Gy versus 80 Gy in localized prostate cancer: 5-Year results of GETUG 06 randomized trial;Beckendorf;Int J Radiat Oncol,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Patients With Prostate Cancer? Early Results From the HOPE Trial;International Journal of Radiation Oncology*Biology*Physics;2023-12

2. Safety of Ultrahypofractionated Pelvic Nodal Irradiation in the Definitive Management of Prostate Cancer: Systematic Review and Meta-analysis;International Journal of Radiation Oncology*Biology*Physics;2023-10

3. Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial;Clinical and Translational Radiation Oncology;2023-05